[go: up one dir, main page]

ES8602673A1 - Un metodo para producir acidos 1,4-dihidro-4-oxo-quinolin-3-carboxilico - Google Patents

Un metodo para producir acidos 1,4-dihidro-4-oxo-quinolin-3-carboxilico

Info

Publication number
ES8602673A1
ES8602673A1 ES533916A ES533916A ES8602673A1 ES 8602673 A1 ES8602673 A1 ES 8602673A1 ES 533916 A ES533916 A ES 533916A ES 533916 A ES533916 A ES 533916A ES 8602673 A1 ES8602673 A1 ES 8602673A1
Authority
ES
Spain
Prior art keywords
antibacterial compounds
quinoline
quinoline antibacterial
compounds
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES533916A
Other languages
English (en)
Other versions
ES533916A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of ES533916A0 publication Critical patent/ES533916A0/es
Publication of ES8602673A1 publication Critical patent/ES8602673A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

METODO PARA PRODUCIR ACIDOS 1,4-DIHIDRO-4-OXO-QUINOLIN-3-CARBOXILICOS.CONSISTE EN HACER REACCIONAR EL COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA ZH PARA OBTENER ACIDOS 1,4-DIHIDRO-4-OXO-QUINOLIN-3-CARBOXILICOS DE FORMULA (I). SIENDO: R, ANILLO HETEROCICLICO AROMATICO DE C 5 A 7 O FENILO DE FORMULA (III); R1, H, O GRUPO PROTECTOR DE CARBOXI; R2, H, HAL, NITRO, CARBOXILO, CIANO, METILENDIOXI, ALQUILO DE C 1 A 6, Y UN GRUPO DE FORMULA (IV); R6, H, ALQUILO DE C 1 A 10 Y SUS DERIVADOS SUSTITUIDOS; R8 ES UN GRUPO SALIENTE; Y, -0-, O -S-; R3, H, ALQUILO DE C 1 A 6 Y OTROS; Y Z, ANILLO HETEROCICLICO ALIFATICO DE C 4 A 7 Y SUS DERIVADOS SUSTITUIDOS.SE UTILIZA EN FARMACOLOGIA COMO ANTIBACTERIANO.
ES533916A 1983-07-18 1984-07-02 Un metodo para producir acidos 1,4-dihidro-4-oxo-quinolin-3-carboxilico Expired ES8602673A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51471683A 1983-07-18 1983-07-18
US57422784A 1984-01-26 1984-01-26
US59785484A 1984-04-09 1984-04-09

Publications (2)

Publication Number Publication Date
ES533916A0 ES533916A0 (es) 1985-12-01
ES8602673A1 true ES8602673A1 (es) 1985-12-01

Family

ID=27414582

Family Applications (1)

Application Number Title Priority Date Filing Date
ES533916A Expired ES8602673A1 (es) 1983-07-18 1984-07-02 Un metodo para producir acidos 1,4-dihidro-4-oxo-quinolin-3-carboxilico

Country Status (14)

Country Link
EP (1) EP0131839B1 (es)
KR (1) KR900005025B1 (es)
AT (1) ATE40551T1 (es)
AU (1) AU576323B2 (es)
DE (2) DE3476540D1 (es)
DK (1) DK168289B1 (es)
ES (1) ES8602673A1 (es)
GR (1) GR79948B (es)
IE (1) IE58333B1 (es)
IL (1) IL72100A (es)
LU (1) LU90159I2 (es)
MX (1) MX9202947A (es)
NL (1) NL970010I2 (es)
NZ (1) NZ208470A (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0154780B1 (en) * 1984-01-26 1990-04-11 Abbott Laboratories Quinoline antibacterial compounds
EP0181521A1 (en) * 1984-10-19 1986-05-21 Otsuka Pharmaceutical Co., Ltd. Antimicrobial 1-substituted Phenyl-4-oxoquinoline-3-carboxylic acid compounds
US4617308A (en) * 1985-01-25 1986-10-14 Warner-Lambert Company 7-substituted amino-1-aryl-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids and derivatives thereof as antibacterial agents
US4755513A (en) * 1985-01-30 1988-07-05 Otsuka Pharmaceutical Company, Limited Antimicrobial 1-substituted phenyl-4-oxoquinoline-3-carboxylic acid compounds
US4684648A (en) * 1985-05-10 1987-08-04 Otsuka Pharmaceutical Company Limited Antimicrobial 1-substituted phenyl-4-oxoquinoline-3-carboxylic acid compounds and compositions thereof
IT1200470B (it) * 1985-05-10 1989-01-18 Schering Spa Composti ad attivita' antibatterica,loro preparazione e composizioni farmaceutiche relative
DE3517535A1 (de) * 1985-05-15 1986-11-20 Bayer Ag, 5090 Leverkusen 1-aryl-4-chinolon-3-carbonsaeuren
IT1201437B (it) * 1985-07-22 1989-02-02 Uason Srl Derivato dell'acido chinolin-3-carbossilico,procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
IN166416B (es) * 1985-09-18 1990-05-05 Pfizer
EP0224121A3 (en) * 1985-11-19 1987-11-11 ROTTAPHARM S.p.A. 7-[4-amino-piperazinyl]- or 7-[4-chloro-piperazinyl]quinolinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
DE3601567A1 (de) * 1986-01-21 1987-07-23 Bayer Ag 7-(azabicycloalkyl)-chinoloncarbonsaeure- und -naphthyridon-carbonsaeure-derivate
US5153204A (en) * 1986-03-01 1992-10-06 Bayer Aktiengesellschaft 7-(1-Pyrrolidinyl)-quinolonecarboxylic acid derivatives
DE3606698A1 (de) * 1986-03-01 1987-09-03 Bayer Ag 7-(1-pyrrolidinyl)-chinoloncarbonsaeure -derivate
US4762845A (en) * 1986-05-21 1988-08-09 Abbott Laboratories 7-(3-Substituted imino-1-pyrrolidinyl)-quinolone-3-carboxylic acids
DE3766299D1 (de) * 1986-07-04 1991-01-03 Chemie Linz Gmbh 4-chinolon-3-carbonsaeurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
US4771055A (en) * 1986-07-28 1988-09-13 Warner-Lambert Company 7-[[3-(aminomethyl)-3-alkyl]-1-pyrrolidinyl]-quinoline-carboxylic acids
DE3641661A1 (de) * 1986-12-05 1988-06-30 Bayer Ag Verfahren zur herstellung von chinoloncarbonsaeureestern
KR970005911B1 (ko) * 1987-06-24 1997-04-22 치노인 교기스져 에스 베게스제티 테르메케크 기야라 알티 퀴놀린 카복실산 유도체를 제조하는 제조방법
US5380845A (en) * 1987-06-24 1995-01-10 Chinoin Gyogyszer- Es Vegyeszeti Termekek Gyara Rt. Process for the preparation of quinoline carboxylic acid derivatives
US4962112A (en) * 1987-08-04 1990-10-09 Abbott Laboratories 7-(2-methyl-4-aminopyrrolidinyl)naphthryidine and quinoline compounds
NZ225926A (en) * 1987-09-08 1990-04-26 Sterling Drug Inc 7-pyridinyl-4-oxo-3-quinolinecarboxylic acid derivatives, and pharmaceutical compositions
US5039683A (en) * 1987-10-26 1991-08-13 Pfizer Inc. Azetidinyl quinolone carboxylic acids and esters
NZ229605A (en) * 1988-07-15 1990-07-26 Abbott Lab Preparation of 1,4-dihydro-6-fluoro-7-(piperazin-1-yl)-4-oxo-3-quinoline (or naphthyridine) carboxylic acid derivatives
IE76284B1 (en) * 1988-09-22 1997-10-08 Abbott Lab Amino acid quinoline and naphthyridine derivatives
DE3934082A1 (de) * 1989-10-12 1991-04-18 Bayer Ag Chinoloncarbonsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung als antivirale mittel
FR2655545B1 (fr) * 1989-12-11 1994-06-10 Rhone Poulenc Sante Nouvelle application therapeutique des derives des fluoroquinolones.
CA2072366C (en) * 1989-12-29 2002-08-20 Laman A. Al-Razzak Carboxylic acid-metal ion-acid complexes
ES2019551A6 (es) * 1990-04-11 1991-06-16 Ercros Sa Procedimiento para la obtencion de derivados del acido 6-fluor-1, 4-dihidro-4-oxo-7-piperacinil-3-quinlincarboxilico.
DE4120646A1 (de) * 1991-06-22 1992-12-24 Bayer Ag 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
DE4121214A1 (de) * 1991-06-27 1993-01-14 Bayer Ag 7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate
ES2049640B1 (es) * 1992-06-18 1994-12-16 Genesis Para La Investigacion Procedimiento paras la preparacion de acidos quinolin carboxilicos.
DE4303657A1 (de) * 1993-02-09 1994-08-11 Bayer Ag Neue Chinolon- und Naphthyridoncarbonsäurederivate
US5532239A (en) * 1993-08-02 1996-07-02 Assistance Publique - Hopitaux De Paris Therapeutic application of fluoroquinolone derivatives
AU679961B2 (en) * 1993-08-13 1997-07-17 Dong Wha Pharmaceutical Industrial Co., Ltd. Novel quinolone carboxylic acid derivatives
DE4425648A1 (de) * 1994-07-20 1996-01-25 Bayer Ag Neue 6 und 6,8-substituierte 1-[4-(1H-1,2,4-triazol-l-yl-methyl)phenyl] Chinoloncarbonsäuren
KR100299430B1 (ko) * 1995-09-22 2001-09-06 기스케 와구나가, 구사이 요시히로 신규피리돈카르복실산유도체또는그염및이물질을유효성분으로하는항균제
JP4669607B2 (ja) * 1997-09-15 2011-04-13 ザ プロクター アンド ギャンブル カンパニー 抗微生物キノロン類、その組成物およびその使用
SE9904108D0 (sv) * 1999-11-15 1999-11-15 New Pharma Research Ab Nya föreningar
KR200277481Y1 (ko) * 2001-07-16 2002-06-03 김형섭 음식물 낱개 포장장치의 필름 접합장치
US20070197548A1 (en) 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone compositions
US7973022B2 (en) 2006-02-17 2011-07-05 Idexx Laboratories, Inc. Fluoroquinolone carboxylic acid salt compositions
JP6322772B1 (ja) 2016-06-15 2018-05-09 湧永製薬株式会社 新規ピリドンカルボン酸誘導体又はその塩

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1147336A (en) * 1965-06-14 1969-04-02 Lilly Industries Ltd Quinoline-3-carboxylic acid derivatives
US4017622A (en) * 1972-12-18 1977-04-12 Dainippon Pharmaceutical Co., Ltd. Piperazine derivatives
SE444566B (sv) * 1977-09-20 1986-04-21 Bellon Labor Sa Roger 7-dialkylamin-6-halogen-4-oxo-1,4-dihydrokinolin-3-karboxylsyra, forfarande for framstellning derav och farmaceutiskt preparat derav
DE3028520A1 (de) * 1980-07-28 1982-02-25 Dynamit Nobel Ag, 5210 Troisdorf Verfahren zur herstellung von chinolinen, naphtyridinen und anderen stickstoff-bi-heterocyclen
JPS57145862A (en) * 1981-03-06 1982-09-09 Kyorin Pharmaceut Co Ltd Quinolinecarboxylic acid derivative

Also Published As

Publication number Publication date
ES533916A0 (es) 1985-12-01
IL72100A (en) 1988-09-30
ATE40551T1 (de) 1989-02-15
AU576323B2 (en) 1988-08-25
EP0131839A1 (en) 1985-01-23
IE58333B1 (en) 1993-09-08
IE841846L (en) 1985-01-18
IL72100A0 (en) 1984-10-31
NL970010I1 (nl) 1997-05-01
GR79948B (es) 1984-10-31
DK333984D0 (da) 1984-07-06
KR850001171A (ko) 1985-03-16
DK168289B1 (da) 1994-03-07
MX9202947A (es) 1992-07-01
EP0131839B1 (en) 1989-02-01
DE3476540D1 (en) 1989-03-09
KR900005025B1 (ko) 1990-07-18
DE19875001I2 (de) 2001-11-22
DK333984A (da) 1985-01-19
LU90159I2 (fr) 1998-01-21
NL970010I2 (nl) 1997-10-01
NZ208470A (en) 1988-06-30
AU3056384A (en) 1985-01-24

Similar Documents

Publication Publication Date Title
ES8602673A1 (es) Un metodo para producir acidos 1,4-dihidro-4-oxo-quinolin-3-carboxilico
ES8605278A1 (es) Procedimiento perfeccionado para la fabricacion de acido 7- beta-(carboxialquenoilamino)-3-cefem-4-carboxilico
JPS57114555A (en) 3-aryloxy-3-phenylpropylamine and manufacture
IL148516A (en) Retroviral protease inhibiting compound
AU591640B2 (en) Quinolonecarboxylic acid derivatives
ES8604959A1 (es) Un compuesto
TW351718B (en) Acylated aminoalkanimidazoles and -triazoles
AU585091B2 (en) Cephalosporin compounds
JPS6450880A (en) 7-(2-methyl-4-aminopyrrolidinyl)naphthylidine and quinoline compound
AU563168B2 (en) N-pyrazin-2-ylphosporamidates
GB1467942A (en) Amine condensate
TW334426B (en) Piperazine derivatives
MY101939A (en) N-arylsulfonyl-n-pyrimidinylureas

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050905